Enlivex obtains approval for Covid-19 therapy trial expansion to Spain
Phase IIb trail will assess the efficacy and safety of Allocetra when given in addition to the standard of care…
Spain
Latest in
Spain
Grifols’ combination treatment fails to meet endpoints in Covid-19 study
Grifols has reported that the Phase III ‘Inpatient Treatment with Anti-Coronavirus Immunoglobulin’ (ITAC) clinical trial of a combination treatment regimen…
Grifols to initiate new Covid-19 drug trial in Spain
Grifols is set to initiate a clinical trial in Spain to analyse a new Covid-19 drug, which can potentially offer…
BioAegis gets Spanish approval for Phase II Covid-19 trial of gelsolin
US-based BioAegis Therapeutics has received approval from the Spanish Agency for Medicines and Health Products (AEMPS) to conduct a Phase…
COVID-19 coronavirus: Top ten most-affected countries
One Asian country and seven European countries are among the ten most affected list of countries with coronavirus, while more…
Sofpromed to use TrialMaster EDC for oncology clinical trials
Spain-based contract research organisation (CRO) Sofpromed has selected TrialMaster as its preferred electronic data capture (EDC) system to support the…
ESMO 2019: BeiGene presents data on tislelizumab and pamiparib
Biopharmaceutical company BeiGene has presented data on its two investigational drug candidates, anti-PD-1 antibody tislelizumab and PARP inhibitor pamiparib.
Oryzon’s vafidemstat yields positive results in autism patients
Spanish biopharmaceutical firm Oryzon Genomics has reported that vafidemstat led to improvements in aggressive behaviour of autism spectrum disorder (ASD)…